Stock exchanges & markets

Overview Watchlists

DKSH agrees to buy Bayer's Meliane oral contraceptive brand in 30 markets

27. Jul 2026

(AWP Alliance News) - DKSH Holding AG signed an agreement to acquire the rights to Bayer's Meliane oral contraceptive brand across 30 markets in Europe, North Africa, Asia, and the Middle East. The deal expands DKSH's healthcare own-brands portfolio, with a focus on women's health.

Meliane generated net sales of about CHF 15 million in 2025. Closing is expected in the third quarter of 2026, subject to customary conditions.

https://www.publicnow.com/view/BB453C45E89F81506DC630E762E685C97C4DD583…

Disclaimer: This news brief was created using generative artificial intelligence. DKSH Holding AG published the original content used to generate this news brief via EQS News on July 27, 2026, and is solely responsible for the information contained therein.

Learn more about our offers

  • Keep a close eye on your favourite shares

    Watchlist

    Don’t miss out on share price trends. Track your favourite shares (CH, EU & US) in real time with customised watchlists.

    Sign up now

  • ETF Compass

    Stock exchanges & markets

    ETFs are becoming increasingly popular. Our ETF Compass helps you maintain an overview. Filter by criteria such as asset class, region, rating, return or costs. 

    Try the ETF Compass now

  • How to find the best shares

    theScreener

    Search through around 6,500 securities using criteria such as opportunities and risks or expected dividend yield.

    Test now